Cementos Pacasmayo Down Nearly 8%, on Pace for Largest Percent Decrease Since November 2024 -- Data Talk

Dow Jones
Nov 22, 2025

Cementos Pacasmayo SAA Sponsored ADR $(CPAC)$ is currently at $6.68, down $0.56 or 7.68%

 

--Would be lowest close since Sept. 11, 2025, when it closed at $6.60

--On pace for largest percent decrease since Nov. 21, 2024, when it fell 9.33%

--Currently down three of the past four days

--Currently down two consecutive days; down 9.43% over this period

--Worst two day stretch since the two days ending April 8, 2025, when it fell 10.34%

--Down 8.18% this week; worst weekly performance since the week ending April 11, 2025, when it fell 12.07%

--Down 8.18% month-to-date

--Up 27.63% year-to-date; on pace for best year on record (Based on available data back to Feb. 8, 2012)

--Down 61.36% from its all-time closing high of $17.28 on May 10, 2013

--Up 15.38% from 52 weeks ago (Nov. 22, 2024), when it closed at $5.79

--Down 11.82% from its 52-week closing high of $7.57 on Nov. 3, 2025

--Up 30.88% from its 52-week closing low of $5.10 on April 11, 2025

--Traded as low as $6.56; lowest intraday level since Sept. 11, 2025, when it hit $6.50

--Down 9.27% at today's intraday low; largest intraday percent decrease since July 28, 2025, when it fell as much as 11.22%

 

All data as of 12:49:14 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

November 21, 2025 12:53 ET (17:53 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10